Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial

    The Lancet Date published:

  • Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials

    The Lancet Date published:

  • Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

    The Lancet Date published:

  • Antihypertensive therapy to prevent recurrent stroke

    Date published:

  • Random errors in the measurement of 10 cardiovascular risk factors

    European Journal of Epidemiology Date published:

  • Effects of omapatrilat on blood pressure and neurohormone levels among 723 individuals with coronary heart disease - The PACIFIC study

    Circulation Date published:

  • Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus

    Journal of Hypertension, Supplement Date published:

  • Dose-dependent effects of folic acid on plasma homocysteine levels among 723 individuals with coronary heart disease: the PACIFIC study

    Journal of the American College of Cardiology Date published:

  • Antihypertensive therapy to prevent recurrent stroke,Künftig gilt: Grundsätzlich blutdrucksenkung anstreben!

    MMW-Fortschritte der Medizin Date published:

  • Prevention of cardiovascular diseases in developing countries

    Journal of Hypertension Date published:

  • Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

    The Lancet Date published:

  • Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

    The Lancet Date published:

  • Pravastatin Therapy and the Risk of Stroke

    New England Journal of Medicine Date published:

  • Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

    Journal of the American College of Cardiology Date published:

  • Reduction in coronary events with pravastatin and proportion of treatment benefit explained by on-study LIPID levels in the LIPID study

    Atherosclerosis Date published:

  • Prevalence of hypertension in CHD patients in the asia-pacific region: the aspac study

    Atherosclerosis Date published: